research
The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)
- Publication date
- 1 January 2016
- Publisher
- 'Dove Medical Press Ltd.'